- Home
- ELMD vs IDYA Comparison
ELMD vs IDYA Comparison
Compare ELMD & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | IDYA |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.7M | 2.9B |
| IPO Year | 2010 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ELMD | IDYA |
|---|---|---|
| Price | $28.73 | $34.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $36.00 | ★ $49.18 |
| AVG Volume (30 Days) | 50.2K | ★ 943.7K |
| Earning Date | 02-10-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.89 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | $66,218,999.00 | ★ $214,834,000.00 |
| Revenue This Year | $14.63 | $2,662.86 |
| Revenue Next Year | $11.54 | N/A |
| P/E Ratio | $30.27 | ★ N/A |
| Revenue Growth | 16.05 | ★ 5377.66 |
| 52 Week Low | $17.73 | $13.45 |
| 52 Week High | $35.56 | $37.08 |
Technical Indicators
Market Signals| Indicator | ELMD | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 57.73 | 51.75 |
| Support Level | $26.98 | $33.11 |
| Resistance Level | $29.44 | $34.45 |
| Average True Range (ATR) | 1.26 | 1.14 |
| MACD | -0.19 | -0.08 |
| Stochastic Oscillator | 57.55 | 42.76 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.